DNA decoder: 5,000 cancer patients get personalized drug matches
NCT ID NCT02155621
First seen Nov 01, 2025 · Last updated Jun 06, 2026 · Updated 31 times
Summary
This study uses full genome sequencing to analyze the DNA of each participant's cancer. The goal is to find the specific genetic changes driving the cancer and match them with targeted drugs. Researchers will track how often this genetic information changes treatment decisions and build a large database to improve future cancer care. The study enrolls 5,000 adults with advanced or metastatic cancers that cannot be cured.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC CANCERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
BC Cancer Agency
RECRUITINGVancouver, British Columbia, V5Z 4E6, Canada
Contact Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.